HRT Financial’s Biodexa Pharmaceuticals BDRX Stock Holding History

HRT Financial’s Portfolio BDRX Stock Details BDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$46K	Buy	+8,906	New	+$102K	﹤0.01%	4339
2026 Q1	–	Sell	-265	Closed	-$24K	–	3801
2025 Q4	$24K	Buy	+265	New	+$60.3K	﹤0.01%	2965
2020 Q4	–	Hold	0	–	-$33K	–	1857
2020 Q3	–	Hold	0	–	–	–	1732

Other funds holding BDRX

StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

HRT Financial's BDRX Position: Q3 2026 in Review

HRT Financial opened a new position in Biodexa Pharmaceuticals (BDRX) in Q3 2026: 8,906 shares worth $46K. The stake represents ﹤0.01% of the portfolio and ranks #4339 among its holdings. This is a return to the name: HRT Financial previously reported a position in BDRX as recently as Q4 2025.

HRT Financial first reported a position in BDRX in Q4 2025 and has held it in 2 quarters since. 4 funds tracked by Wall St. Rank hold BDRX as of Q3 2026.

HRT Financial held 8,906 shares of Biodexa Pharmaceuticals worth $46K as of Q3 2026.
Biodexa Pharmaceuticals was a new HRT Financial position in Q3 2026.
Biodexa Pharmaceuticals made up ﹤0.01% of HRT Financial's portfolio in Q3 2026, its #4339 holding.
HRT Financial first reported a position in Biodexa Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
4 funds tracked by Wall St. Rank held Biodexa Pharmaceuticals as of Q3 2026.

Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.